Buprenorphine Transdermal Delivery System: Bioequivalence Assessment and Adhesion Performance of Two Patch Formulations

<b>Background and Objective:</b> Buprenorphine is an opioid drug indicated for the management of severe and persistent pain. The buprenorphine transdermal patch provides a non-invasive method of rate-controlled drug release, ensuring constant and predictable drug plasma levels over an ex...

詳細記述

書誌詳細

出版年:	Pharmaceutics
主要な著者:	Marcelo Gomes Davanço, Miguel Fortuny, Alejandro Scasso, Jessica Meulman, Fernando Costa, Thalita Martins da Silva, Débora Renz Barreto Vianna, Leonardo de Souza Teixeira, Karini Bruno Bellorio, Ana Carolina Costa Sampaio, Celso Francisco Pimentel Vespasiano
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2024-09-01
主題:	buprenorphine transdermal delivery system patch opioid bioequivalence adhesion
オンライン･アクセス:	https://www.mdpi.com/1999-4923/16/10/1249